2020 NCATS ASPIRE Reduction-to-Practice Challenge Winners, Stage 1

NCATS is happy to announce the winners of the 2020 NCATS ASPIRE Reduction-to-Practice Challenge, Stage 1: Planning Comprehensive Integrated Platforms.
*According to the rules for these ASPIRE Design Challenges, non-U.S. citizens and non-permanent residents were not eligible to win a monetary prize (in whole or in part).


Iterative Learning and Automated Modular Platform for Optimum Nonaddictive Analgesic Discovery

Gaurav Chopra
Ram Samudrala
R. Graham Cooks
Connor W. Coley
Panayotis K. Thanos
Jun-Xu Li

Purdue University
State University of New York (SUNY)
Purdue University
Massachusetts Institute of Technology
University at Buffalo
University at Buffalo

Accelerating Molecular Innovation in Pain through an AI-Driven, Human-Guided and Automated Open Drug Discovery Platform

Daniel H. Robertson
Timothy I. Richardson
Gaurav Chopra
Richard M. van Rijn

Indiana Biosciences Research Institute
Indiana University School of Medicine
Purdue University
Indiana University School of Medicine

Closed Loop Bio-Assay-Chemputer for Next Generation Analgesics (BioChemputer)

Babak Esmaeli-Azad
Leroy Cronin
Sara I. Walker
Philip J. Kitson
S. Hessam M. Mehr
James Zapf
Evan Snyder
Larry H. Ellisman
Shaochen Chen

CiBots, Inc.
University of Glasgow
Arizona State University
University of Glasgow
University of Glasgow
Visionary Pharmaceuticals Inc.
Sanford Consortium for Regenerative Medicine
University of California, San Diego
University of California, San Diego

Development of a Comprehensive Integrated Platform for Translational Innovation in Pain, Opioid Abuse Disorder and Overdose

Jeffrey Skolnick
Andre Ghetti
Nicole Jung
Hongyi Zhou

Georgia Institute of Technology
ANABIOS Corporation
Karlsruhe Institute of Technology
Georgia Institute of Technology

Biotech-in-a-Box, CDD’s Solution for Combating the Opioid Crisis

Barry Bunin
Jacob Bloom
Peter Gedeck
Samantha Jeschonek
Lawrence Callahan
Christopher Lipinski

Collaborative Drug Discovery
Collaborative Drug Discovery
Collaborative Drug Discovery
Collaborative Drug Discovery
U.S. FDA
Christopher A Lipinski, Ph.D., LLC.

Back to top


Contact

Dobrila D. Rudnicki, Ph.D.